SkinHealth Systems (SKIN) Cash from Financing Activities (2020 - 2026)

SkinHealth Systems (SKIN) has 7 years of Cash from Financing Activities data on file, last reported at -$20.9 million in Q1 2026.

• On a quarterly basis, Cash from Financing Activities fell 8262.4% year-over-year to -$20.9 million in Q1 2026; TTM through Mar 2026 was -$195.6 million, a 95.63% decrease from a year earlier, with the FY2025 full-year figure at -$174.9 million, down 10.47% from the prior year.
• Cash from Financing Activities for Q1 2026 stood at -$20.9 million, down from -$512000.0 in the prior quarter.
• Over the last five years, Cash from Financing Activities for SKIN reached as high as -$204000.0 in Q3 2024 and fell as low as -$173.4 million in Q2 2025.
• Historically, Cash from Financing Activities has averaged -$35.1 million across 5 years, with a median of -$2.2 million in 2023.
• Across the five-year window, Cash from Financing Activities jumped 99.57% in 2025 and sank 8262.4% in 2026, its largest moves.
• Year by year, Cash from Financing Activities stood at -$102.5 million in 2022, then jumped by 69.4% to -$31.4 million in 2023, then surged by 97.54% to -$770000.0 in 2024, then jumped by 33.51% to -$512000.0 in 2025, then tumbled by 3983.2% to -$20.9 million in 2026.
• Per Business Quant data, the three most recent Cash from Financing Activities figures were -$20.9 million in Q1 2026, -$512000.0 in Q4 2025, and -$803000.0 in Q3 2025.